Frydman A - Search Results

1

[Pharmacokinetics of cefixime in healthy volunteers after a single oral administration of 200 mg].

Montay G, Le Liboux A, Thebault JJ, Roche G, Frydman A, Gaillot J. Montay G, et al. Among authors: frydman a. Presse Med. 1989 Oct 11;18(32):1583-6. Presse Med. 1989. PMID: 2530537 French.

2

Pharmacokinetics of nicorandil.

Frydman AM, Chapelle P, Diekmann H, Bruno R, Thebault JJ, Bouthier J, Caplain H, Ungethuem W, Gaillard C, Le Liboux A, et al. Frydman AM, et al. Am J Cardiol. 1989 Jun 20;63(21):25J-33J. doi: 10.1016/0002-9149(89)90201-4. Am J Cardiol. 1989. PMID: 2525322

3

Comparative bioavailability study of cefixime administered as tablets or aqueous solution.

Montay G, Masala F, Le Roux Y, Le Liboux A, Uhlrich J, Chassard D, Thebault JJ, Roche G, Frydman A. Montay G, et al. Among authors: frydman a. Drugs. 1991;42 Suppl 4:6-9. doi: 10.2165/00003495-199100424-00004. Drugs. 1991. PMID: 1725153 Clinical Trial.

4

Pharmacokinetics of pyrimethamine in healthy young volunteers using a new solid phase extraction/HPLC method.

Le Liboux A, Duquesne H, Montay G, Chassard D, Pichard E, Thebault JJ, Frydman A, Gaillot J. Le Liboux A, et al. Among authors: frydman a. Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:284-90. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1820893 Clinical Trial.

5

Pharmacokinetics of sparfloxacin in humans after single oral administration at doses of 200, 400, 600, and 800 mg.

Montay G, Bruno R, Vergniol JC, Ebmeier M, Le Roux Y, Guimart C, Frydman A, Chassard D, Thebault JJ. Montay G, et al. Among authors: frydman a. J Clin Pharmacol. 1994 Nov;34(11):1071-6. doi: 10.1002/j.1552-4604.1994.tb01983.x. J Clin Pharmacol. 1994. PMID: 7876398 Clinical Trial.

6

Pharmacokinetics of spiramycin in man.

Frydman AM, Le Roux Y, Desnottes JF, Kaplan P, Djebbar F, Cournot A, Duchier J, Gaillot J. Frydman AM, et al. J Antimicrob Chemother. 1988 Jul;22 Suppl B:93-103. doi: 10.1093/jac/22.supplement_b.93. J Antimicrob Chemother. 1988. PMID: 3182451

7

A phase I, double-blind, placebo-controlled study of the tolerance and pharmacokinetic behaviour of RP 59500.

Etienne SD, Montay G, Le Liboux A, Frydman A, Garaud JJ. Etienne SD, et al. Among authors: frydman a. J Antimicrob Chemother. 1992 Jul;30 Suppl A:123-31. doi: 10.1093/jac/30.suppl_a.123. J Antimicrob Chemother. 1992. PMID: 1399944 Clinical Trial.

8

Evaluation of Bayesian estimation to discriminate subpopulations of patients with altered pharmacokinetics using fragmentary data: a pilot study with pefloxacin.

Bruno R, Rosier P, Iliadis A, Le Roux Y, Montay G, Frydman A, Gaillot J. Bruno R, et al. Among authors: frydman a. Eur J Drug Metab Pharmacokinet. 1991;Spec No 3:338-45. Eur J Drug Metab Pharmacokinet. 1991. PMID: 1820906

9

Comparison of the pharmacokinetic profiles of three low molecular mass heparins--dalteparin, enoxaparin and nadroparin--administered subcutaneously in healthy volunteers (doses for prevention of thromboembolism).

Collignon F, Frydman A, Caplain H, Ozoux ML, Le Roux Y, Bouthier J, Thébault JJ. Collignon F, et al. Among authors: frydman a. Thromb Haemost. 1995 Apr;73(4):630-40. Thromb Haemost. 1995. PMID: 7495071 Clinical Trial.

10

Effect of diet on the single- and multiple-dose pharmacokinetics of sustained-release ketoprofen.

Le Liboux A, Teule M, Frydman A, Oosterhuis B, Jonkman JH. Le Liboux A, et al. Among authors: frydman a. Eur J Clin Pharmacol. 1994;47(4):361-6. doi: 10.1007/BF00191169. Eur J Clin Pharmacol. 1994. PMID: 7875189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters